Elsevier

Vascular Pharmacology

Volume 48, Issue 1, January 2008, Pages 38-46
Vascular Pharmacology

Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells

https://doi.org/10.1016/j.vph.2007.11.004Get rights and content

Abstract

Vascular inflammatory process has been suggested to play a key role in the initiation and progression of atherosclerosis, a major complication of diabetes mellitus. Lycopus lucidus Turcz. has been used as an oriental traditional medicine including Korea and its crude drug is known to have an anti-inflammatory effect. Thus we investigated whether the aqueous extract of the leaves of L. lucidus Turcz. (ALT) suppresses vascular inflammatory process induced by high glucose in primary cultured human umbilical vein endothelial cells (HUVEC). Western blot analysis revealed that incubation of HUVEC with high glucose increased cell adhesion molecules (CAMs) expression levels. However, high glucose-induced increase of CAMs expression was significantly attenuated by pretreatment with ALT in a dose-dependent manner. The enhanced cell adhesion between monocyte and HUVEC induced by high glucose was also blocked by pretreatment with ALT. High glucose-induced hydrogen peroxide production and DCF-sensitive intracellular reactive oxygen species (ROS) formation. Pretreatment with ALT inhibited high glucose-induced ROS formation. In addition, ALT suppressed the translocation and promoter transcriptional activity of NF-κB increased in high glucose condition. Taken together, the present data suggested that ALT could suppress high glucose-induced vascular inflammatory process, which may be closely related with the inhibition of ROS and NF-κB activation in HUVEC.

Introduction

Macrovascular complications including atherosclerosis are the leading cause of morbidity and mortality in patients with diabetes mellitus (DM) (Kannel and McGee, 1979, Ruderman and Haudenschild, 1984). Hyperglycemia is thought to be an important regulator of vascular lesion development. Hyperglycemia-induced endothelial dysfunctions, along with hypercoagulable potential of diabetes mellitus, accelerate the process of atherothrombotic complications. Vascular disorders, through overexpression of adhesion molecules and cytokines, are thought to participate in the pathogenesis of atherosclerosis. In particular, endothelial cells in human atherosclerotic lesions have been shown to increase cell adhesion molecules (CAMs) expression such as intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial selectin (E-selectin) (Lopes-Virella and Virella, 1992, Quagliaro et al., 2005). Under these conditions, numerous leukocytes adhere to vascular endothelium, transmigrate the endothelium, and aggravate endothelial dysfunction and tissue injury. Endothelial cells and monocytes cultured in media of high glucose concentration exhibit increased adhesiveness, suggesting that leukocyte binding through adhesion molecules increases under conditions of high glucose concentration (Kwon et al., 2004). However, the underlying mechanisms between hyperglycemia and vascular disease remain unclear.

Oxidative injury, due to the high glucose concentration, plays a central role in the development of diabetic complications (Brownlee, 2001). Under oxidative stress, macrophages generate reactive oxygen species (ROS) such as superoxides, peroxynitrite, leading to LDL oxidation (Steinberg, 1997). The production of ROS together with inflammatory factors including chemokines, cytokines, and adhesion molecules has been shown to be increased in atherosclerotic lesions (Liao et al., 1994, Ham and Skoryna, 2004). Inflammatory responses, including inflammatory gene transcription, appear to involve free radicals or oxidative stresses, and thus anti-oxidants or free radical scavengers can suppress inflammatory gene expression. However, the effect of Lycopus lucidus Turcz. on high glucose-induced oxidative stress was not cleared in vascular endothelial cell.

Previous studies have shown that high glucose as well as TNF-α activate nuclear factor-κB (NF-κB), one of the transcription factors for pro-inflammatory genes. NF-κB is present in the cytoplasm as an inactive form bound to its inhibitor molecule, inhibitory factor of NF-κB-α (IκB-α). Translocation of NF-κB form the cytoplasm to the nucleus is preceded by the phosphorylation, ubiquitination and proteolytic degradation of IκB-α (Thurberg and Collins, 1998). It is hypothesized that high glucose-induced CAMs expression may depend upon activation of NF-κB.

The Labiatae plant, L. lucidus Turcz. has been used for centuries as an oriental traditional medicine. This crude drug is used for treatment of menstrual disorder and inflammatory disease (Park, 2004, Shin et al., 2005). L. lucidus Turcz. contains three phenolic compounds, rosmarinic acid, methyl rosmarinate, ethyl rosmarinate, and two flavonoids, luteolin, luteolin-7-O-beta-d-glucuronide methyl ester, and it has been known to have anti-oxidative and anti-inflammation effects (Woo and Paio, 2004). However, the anti-inflammatory action of L. lucidus Turcz. under the diabetic condition has not been well examined. Because we previously found that the aqueous fractions of L. lucidus Turcz. leaves have more potent anti-oxidant activities than ethanol soluble fraction (unpublished data 2006), we used aqueous extracts of L. lucidus Turcz. (ALT) Thus, we investigated whether ALT suppresses vascular inflammatory process induced by high glucose in primary cultured human umbilical vein endothelial cells (HUVEC).

Section snippets

Materials

d-glucose, l-glucose, d-mannitol, β-actin and goat anti-mouse IgG conjugate fluorescein isothiocyanate (FITC) were purchased from Sigma Chemical Company (St. Louis, MO). Lipofectamine LTX was purchased from Invitrogen Inc (Carlsbad, CA). Mouse monoclonal antibody to ICAM-1 was obtained from Zymed LALTratories Inc (San Francisco, CA). Mouse monoclonal antibodies to VCAM-1 and E-selectin were obtained from R&D systems Inc (Minneapolis, MN). NF-κB and IκB-α were purchased from Cell Signaling

Effect of high glucose on vascular inflammation

The concentration responses of high glucose on CAMs expression such as ICAM-1, VCAM-1, and E-selectin were determined by cell ELISA. Exposure to the primary cultured HUVEC to high glucose significantly increased expression of ICAM-1, VCAM-1, and E-selectin after incubation with 25 mM d-glucose (Fig. 1A. High glucose concentration can result in altered medium osmolarity. To rule out the involvement of hyperosmolarity in 25 mM glucose-induced increase of ICAM-1, VCAM-1, and E-selectin expression,

Discussion

This report presents evidence suggesting that ALT blocked the high glucose-induced vascular inflammation via inhibition of ROS and NF-κB in primary cultured HUVEC. Over the past decade, a prominent role of inflammation has been appreciated in the pathogenesis of atherosclerosis. One of the earliest events in vascular inflammation process is the adhesion of monocytes to the endothelium, which is followed by their infiltration and differentiation into macrophages. This key step is mediated by an

Acknowledgements

This study was supported by the grants of the Oriental Medicine R&D Project (03-PJ9-PG6-SO02-0001) to Dr. HS Lee funded by Ministry of Health and Welfare and Technology and a grant [L06010] to Dr. DG Kang funded by Korea Institute of Oriental Medicine.

References (38)

  • NoguchiN. et al.

    Inhibition of THP-1 cell adhesion to endothelial cells by a-tocopherol and a-tocotrienol is dependent on intracellular concentration of the antioxidants

    Free Radical Biology & Medicine

    (2003)
  • PiconiL. et al.

    Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase

    Journal of Thrombosis and Haemostasis

    (2004)
  • QuagliaroL. et al.

    Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production

    Atherosclerosis

    (2005)
  • RimbachG. et al.

    Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells

    Molecular Cell Biology Research Communications: MCBRC

    (2000)
  • RudermanN.B. et al.

    Diabetes as an atherogenic factor

    Progress in Cardiovascular Diseases

    (1984)
  • ShinT.Y. et al.

    Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model

    Toxicology and Applied Pharmacology

    (2005)
  • SteinbergD.

    Low density lipoprotein oxidation and its pathobiological significance

    Journal of Biological Chemistry

    (1997)
  • TakiH. et al.

    Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium

    Life Sciences

    (1996)
  • TsunekiH. et al.

    Coenzyme Q10 prevents high glucose-induced oxidative stress in human umbilical vein endothelial cells

    European Journal of Pharmacology

    (2007)
  • Cited by (53)

    • Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice

      2019, Phytomedicine
      Citation Excerpt :

      It has been reported that aerial parts of L. lucidus show multiple pharmacological activities, including anticancer, antioxidant, antibacterial, anti-inflammatory, and thyroid-regulating effects (Beer et al., 2008; Yang et al., 2010; Yu et al., 2011). Previous studies have shown that an aqueous extract of L. lucidus ameliorates streptozotocin-induced diabetic renal damage (Shin et al., 2005) and suppresses the high-glucose-induced vascular inflammation process (Lee et al., 2008). In addition, the pure compounds luteolin and quercetin have been reported to inhibit hepatic de novo lipid synthesis in HepG2 cells and to improve NAFLD in db/db mice, respectively (Vidyashankar et al., 2013; Yin et al., 2017).

    • Screening and identification of the metabolites in rat urine and feces after oral administration of Lycopus lucidus Turcz extract by UHPLC-Q-TOF-MS mass spectrometry

      2016, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
      Citation Excerpt :

      Phytochemical studies of L. lucidus Turcz have been led to the isolation of the phenolic compounds such as rosmarinic acid, caffeic acid, and ferulic acid [2,3], flavonoids such as luteolin, quercetin, isoquercitrin, chrysoeriol, and rutin [2–5], as well as oligosaccharides [6]. Several pharmacological investigations have demonstrated that L. lucidus Turcz has multiple biological activities, including antioxidant activity [7–9], inhibition of high glucose induced vascular inflammation [10], anti-allergic effect [11], immune activity [12,13], antimicrobial activity [8], anticancer [8], and acaricidal activity [14]. Moreover, the aqueous extract of L. lucidus Turcz can ameliorate streptozotocin-induced diabetic renal damage [15].

    View all citing articles on Scopus
    View full text